Filing Details

Accession Number:
0001493152-23-032829
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-15 18:27:44
Reporting Period:
2023-09-14
Accepted Time:
2023-09-15 18:27:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1873835 Immix Biopharma Inc. IMMX Pharmaceutical Preparations (2834) 454869378
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1889522 Carey Ng C/O Immix Biopharma, Inc.
11400 West Olympic Blvd., Suite 200
Los Angeles CA 90064
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-14 10,000 $2.58 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,025,221 Indirect See footnote
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $2.51 to $2.60, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
  2. Carey Ng is the Managing Director of Mesa Verde Venture Partners III, LP ("Mesa Verde") and in such capacity has the right to vote and dispose of the securities held by such entity.